ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Measurement"

  • Abstract Number: 2621 • ACR Convergence 2024

    Trends in Disease Activity in Rheumatoid Arthritis over 2009-2023 Utilizing DAS28-CRP Inferred from Electronic Health Records

    David Cheng1, Vidul Panickan2, Andrew Cagan3, Gregory McDermott4, Mary Jeffway3, Ying Qi5, Feng Liu3, Michael Weinblatt6, Nancy Shadick5, Tianxi Cai7 and Katherine Liao3, 1Massachusetts General Hospital, Boston, MA, 2Harvard Medical School, Boston, MA, 3Brigham and Women's Hospital, Boston, MA, 4Brigham and Women’s Hospital, Brookline, MA, 5Brigham and Women’s Hospital, Boston, MA, 6Brigham and Women's Hospital/ Harvard Medical School, Waban, MA, 7Harvard T.H. Chan School of Public Health, Boston, MA

    Background/Purpose: Systematic measurement and documentation of disease activity in RA patients is key for monitoring quality of care and is an important outcome and predictor…
  • Abstract Number: 0392 • ACR Convergence 2024

    Evaluation for the Presence of Antibodies to Malondialdehyde-Acetaldehyde Adduct in Juvenile Idiopathic Arthritis and Its Subtypes

    Geoffrey Thiele1, Panteha Hayati Rezvan2, Michal Cidon2, Carlos Hunter3, Michael Duryee3, Ted Mikuls3 and Geoffrey Thiele3, 1Children's Hospital of Los Angeles, Omaha, NE, 2Children's Hospital of Los Angeles, Los Angeles, CA, 3University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Studies of rheumatoid arthritis (RA) have shown that malondialdehyde-acetaldehyde (MAA) protein adducts and anti-MAA immune responses play a pathogenic role in disease progression. Expression of…
  • Abstract Number: 0404 • ACR Convergence 2024

    Methotrexate Adherence in JIA: Use of Electronic Health Record-Linked Pharmacy DispensingData

    Dori Abel1, David Anderson1, Michael Kallan2, Levon Utidjian3, Jon Burnham4, Joyce Chang5, Chen Kenyon3 and Sabrina Gmuca1, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, 3Children's Hospital of Philadelphia, Philadelphia, 4Children's Hospital of Philadelphia, Bryn Mawr, PA, 5Boston Children's Hospital, Boston, MA

    Background/Purpose: The extent to which adherence to prescribed treatment regimens contributes to differential disease outcomes in JIA – and demographic disparities in these outcomes –…
  • Abstract Number: 0644 • ACR Convergence 2024

    Scoping Literature Review to Identify Candidate Domains for the SLE OMERACT Core Outcome Set

    Wils Nielsen1, Fadi Kharouf2, Carolina Munoz-Grajales3, Aarabi Thayaparan4, Melanie Anderson5, Lee Simon6, Maya Desai7, Ioannis Parodis8, Alfred Kim9, Yvonne Enman10, Kathleen Bingham11, Dennisse Bonilla11, Julian Thumboo12, Marta Mosca13, Martin Aringer14, Eric Morand15, Ian Bruce16, Vibeke Strand17 and Zahi Touma4, 1University of Toronto, Markham, ON, Canada, 2University Health Network and University of Toronto, Toronto, ON, Canada, Toronto, ON, Canada, 3UHN/TWH, Toronto, ON, Canada, 4University of Toronto, Toronto, ON, Canada, 5The Institute for Education Research, Library and Information Services, University Health Network, Toronto, ON, Canada, 6SDG LLC, West Newton, MA, 7Ontario College of Art and Design University, Toronto, ON, Canada, 8Karolinska Institutet, Karolinska University Hospital; Örebro University, Solna, Sweden, 9Washington University School of Medicine, Division of Rheumatology, Department of Medicine, St Louis, MO, 10Karolinska Institutet, Stockholm, Sweden, 11University Health Network, Toronto, ON, Canada, 12Singapore General Hospital, Singapore, Singapore, 13University of Pisa, Department of Clinical and Experimental Medicine - Rheumatology Unit, Pisa, Italy, 14University Medical Center and Faculty of Medicine TU Dresden, Dresden, Germany, 15School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia, 16Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom, 17Division of Immunology/Rheumatology, Stanford University, Palo Alto, CA

    Background/Purpose: The Outcome Measures in Rheumatology (OMERACT) Systemic Lupus Erythematosus (SLE) Working Group was re-established in 2018 to update the SLE Core Outcome Set (COS)…
  • Abstract Number: 0721 • ACR Convergence 2024

    Does Serial ANCA Testing Help Predict the Risk of Relapse in Granulomatosis with Polyangiitis? A Single-center Cohort Study

    Xavier Puéchal1, Michele Iudici1, Elodie Perrodeau2, Claire Goulvestre3, Pascal cohen4, Alexis Régent1, Luc Mouthon5, Loïc Guillevin4, Raphael Porcher6 and Benjamin Terrier7, 1National Referral Center For Rare Systemic Autoimmune Diseases, Paris, France, 2Hôtel-Dieu, Paris, France, 3Laboratoire d'immunologie, Hôpital Cochin, AP-HP, Paris, Ile-de-France, France, 4National Referral Center For Rare Systemic Autoimmune Diseases, Paris, Ile-de-France, France, 5Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes et Autoinflammatoires Rares d'Ile de France de l’Est et de l’Ouest, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France, 6Department of Rheumatology, Bicêtre AP-HP Hôpital, Université Paris-Saclay, Paris, Ile-de-France, France, 7Service de Médecine interne, Hôpital Cochin, AP-HP, Paris, Ile-de-France, France

    Background/Purpose: ANCA-associated vasculitis (AAV) is a frequently relapsing disease for which a meta-analysis concluded that an increase or persistence of ANCA during remission is only…
  • Abstract Number: 0867 • ACR Convergence 2024

    Development of a Remote Patient Monitoring System Based on a Novel Digital Biomarker for Swelling in Rheumatoid Arthritis

    Marc Blanchard1, Cinja Koller2, Jules Maglione3, Patrick Hermann1 and Thomas Hügle3, 1Lausanne University Hospital, Lausanne, Vaud, Switzerland, 2Doctoral School, Faculty of Biology and Medicine, University of Lausanne, Genève, Vaud, Switzerland, 3Lausanne University Hospital, Lausanne, Switzerland

    Background/Purpose: Rheumatoid arthritis (RA) care faces challenges due to a shortage of healthcare providers, an increasing patient population and the remote locations of many patients.…
  • Abstract Number: 1018 • ACR Convergence 2024

    Analysis of Medication Usage and Monthly Costs in Hospitalized Patients with Rheumatic Diseases: A Retrospective Observational Study

    Daniela Alejandra Salcedo-Soto1, Ana Cecilia Bardan-Inchaustegui2, Pablo Gamez-Siller3, Deynna Montserrat Lara Mendez4, Diana Elsa Flores-Alvarado5, Jorge Esquivel-Valerio6, Jesus Cardenas-de la Garza2 and Dionicio Galarza-Delgado7, 1Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey, Mexico, 2Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 3Facultad de Medicina UANL, Monterrey, Nuevo León, Mexico, 4Hospital Universitario Dr José Eleuterio González, Monterrey, Nuevo León, Mexico, 5Hospital Universitario Jose Eleuterio Gonzalez, Monterrey, Nuevo León, Mexico, 6Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, MONTERREY, Mexico, 7UANL Hospital Universitario, Monterrey, Nuevo León, Mexico

    Background/Purpose: Costs associated with rheumatic diseases significantly affect a considerable portion of patients’ income. The monthly income of northeastern Mexican families has been reported to…
  • Abstract Number: 1060 • ACR Convergence 2024

    Therapeutic Hydroxychloroquine Blood Levels Predict Lower Mean Frequency of Recurrent Acute Care Utilization in Lupus

    Shivani Garg1, Giancarlo Valiente2, Callie Saric1, Betty Chewning3 and Christie Bartels4, 1University of Wisconsin, School of Medicine and Public Health, Madison, Madison, WI, 2University of Wisconsin, School of Medicine and Public Health, Madison, 3University of Wisconsin, School of Pharmacy, Madison, 4University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: Nonadherence to hydroxychloroquine (HCQ) is highly prevalent in lupus (or SLE) and two-fold higher in patients of Black race or Hispanic ethnicity. While HCQ…
  • Abstract Number: 1069 • ACR Convergence 2024

    Improving Triage Accuracy of Unclear Rheumatology Referrals: A Quality Improvement Study

    Stephanie Gottheil1, Chiara Gottheil2 and Joseph Carson3, and Canadian Rheumatology Association - CIORA Grant, 1London Rheumatology, London, 2London Rheumatology, London, Canada, 3London Rheumatology, London, ON, Canada

    Background/Purpose: Patients with early inflammatory arthritis (EIA) need to be seen urgently to initiate treatment. Our community rheumatology clinic in Ontario, Canada was concerned that…
  • Abstract Number: 1074 • ACR Convergence 2024

    Bending the Curve on Inbox Bloat: A Patient Portal Project to Mature-the-Message via Nurse Triage to Reduce Provider Inbox Time

    Christie Bartels1, Sancia Ferguson2, Carmen Campbell1, Lori Zemlicka3, Amanda Weber3, Andrew Holt1 and Elizabeth R. Trowbridge4, 1University of Wisconsin School of Medicine and Public Health, Madison, WI, 2University of Wisconsin, Madison, Madison, WI, 3UW Health Rheumatology, Madison, WI, 4Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: Clinical demands have grown, in part, from rising use of patient portals, while traditional clinic nurse triage has focused on phone-based care. We sought…
  • Abstract Number: 1081 • ACR Convergence 2024

    Evaluation of Methods for Ascertainment and Categorization of Race and Ethnicity for Clinical Research: An Umbrella Review

    Teresa Semalulu1, Melanie Anderson2, Shahad Al-Matar1, SADEEM ALFRAIH1, Azza Eissa3, Emma Neary4, Fadi Kharouf5, Abimbola Saka3, Zayd Schafer6, Zahi Touma1 and Sindhu Johnson7, 1University of Toronto, Toronto, ON, Canada, 2The Institute for Education Research, Library and Information Services, University Health Network, Toronto, ON, Canada, 3University of Toronto, Toronto, 4McGill University, Montreal, QC, 5University Health Network and University of Toronto, Toronto, ON, Canada, Toronto, ON, Canada, 6American University of Antigua, Saint John's, 7Division of Rheumatology, Department of Medicine, Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western and Mount Sinai Hospitals; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Race and ethnicity are increasingly evaluated in rheumatology research due to their influence on health outcomes, yet there remains heterogeneity in their interpretation and…
  • Abstract Number: 1723 • ACR Convergence 2024

    Clustering Analysis with Unsupervised Machine Learning Process to Phenotype the Cardiovascular Risk of Patients with Rheumatoid Arthritis Beyond the 10-year Prediction Algorithm

    Fabio Cacciapaglia1, Vincenzo Venerito2, Gian Luca Erre3, Matteo Piga4, Andreina Manfredi5, Garifallia Sakellariou6, Ombretta Viapiana7, Elisa Gremese8, Elena Bartoloni Bocci9, Francesca Romana Spinelli10 and Fabiola Atzeni11, and "Cardiovascular Obesity and Rheumatic DISeases" Study Group of the Italian Society of Rheumatology, 1Rheumatology Unit DiMePRe-J, University and AOU Policlinico of Bari, Italy, Bari, Italy, 2Rheumatology Unit, DiMePRe-J University of Bari, Bari, Italy, 3Rheumatology Unit - University of Sassari, Sassari, Italy, 4Rheumatology Unit - University of Cagliari, Cagliari, Italy, 5University of Modena and Reggio Emilia, Modena, 6Department of Internal Medicine and Medical Therapy, University of Pavia, and Istituti Clinici Scientifici Maugeri IRCCS Pavia,, Pavia, Italy, 7Rheumatology Unit, University of Verona, Verona, Italy, 8Catholic University of the Sacred Heart, Rome, Rome, Italy, 9Rheumatology Unit. Department of Medicine, Perugia, Perugia, Italy, 10Sapienza University of Rome, Rome - Italy, Roma, Rome, Italy, 11University of Messina, Italy, Messina, Italy

    Background/Purpose: Rheumatoid arthritis (RA) patients are at increased cardiovascular (CV) risk, but traditional CV risk factors and available 10-year CV risk estimation models may not…
  • Abstract Number: 2068 • ACR Convergence 2024

    Poloxamers 188 & 182 Are Effective in Repairing the Membrane Resealing Defect in Myositis

    Shane Bruckner1, Braden Zeno2, Gianni Giarrano3, Alexis Tucker3, Hannah Bulgart4, Brian Paleo3, Kassidy Banford3, Nicholas Young4, Rohit Aggarwal5, Chester Oddis6, Paula Clemens7, Dana Ascherman8, Noah Weisleder1 and Wael Jarjour9, 1Ohio State University, Columbus, OH, 2Ohio State, Upper Arlington, OH, 3Ohio State University, Columbus, 4The Ohio State University Wexner Medical Center, Columbus, OH, 5Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA, Pittsburgh, PA, 6Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 7University of Pittsburgh, Pittsburgh, 8Division of Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, 9The Ohio State University, Columbus, OH

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) are a group of disorders in which autoimmune responses produce a chronic state of inflammation resulting in degeneration of skeletal…
  • Abstract Number: 2441 • ACR Convergence 2024

    Investigating Kidney Disease Risks in Systemic Sclerosis (SSc) – Effects of Proton Pump Inhibitors (PPI): Retrospective Analysis

    Irakli Tskhakaia and Arthur Lau, Jefferson Einstein Hospital, Philadelphia, PA

    Background/Purpose: Systemic Sclerosis (SSc) patients often experience gastrointestinal complications, frequently managed with proton pump inhibitors (PPIs). Despite evidence of PPI-related chronic kidney disease (CKD) risk in…
  • Abstract Number: L15 • ACR Convergence 2023

    AR882, an Efficacious and Selective URAT1 Inhibitor for Patients with Chronic Gouty Arthritis and Subcutaneous Tophi: Results from a Global, Prospective, Proof-of-Concept Trial Using Dual Energy Computed Tomography

    Robert Keenan1, James Cheng-Chung WEI2, Sarah Morris3, Pamella Mundell3, Wen Wei3, Ke Shi3, Zancong Shen3, Vijay Hingorani4, Shunqi Yan3, Bahram Kiani5 and Litain Yeh3, 1Arthrosi Therapeutics, Inc., Chapel Hill, NC, 2Chung Shan Medical University, Taichung, Taiwan (Republic of China), 3Arthrosi Therapeutics, Inc., San Diego, CA, 4Vanguard Healthsciences, Inc., San Diego, CA, 5Wake Forest University School of Medicine, Winston-Salem, NC

    Background/Purpose: AR882 is a novel and selective URAT1 inhibitor currently in clinical stage development for the treatment of gout and tophaceous gout and has demonstrated…
  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology